In the article by Scirica et al, “Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial,” which appeared in the October 28, 2014 issue of the journal (Circulation. 2014;130:1579-1588. doi:10.1161/CIRCULATIONAHA.114.010389), the authors discovered an error in the original coding that incorrectly calculated the number of excess hospitalization for heart failure events per 1000 patients treated with saxagliptin. The incorrect data are presented in portions of Figures 2, 3, Supplemental Figure V, and in 1 sentence in the Results section. Despite the changes to these numbers, there were no qualitative differences based on the updated results. Therefore, the discussion and conclusions remain valid and have not been amended. The authors apologize for this error.
- © 2015 American Heart Association, Inc.